Evidence
J Perinatol. 2024 Jan 24. doi: 10.1038/s41372-024-01882-x. Online ahead of print.
ABSTRACT
OBJECTIVE: To estimate trends in maternal opioid use disorder (OUD) and neonatal abstinence syndrome (NAS) in Maine using the most recent data available.
STUDY DESIGN: We used hospital discharge data to estimate the annual prevalence of maternal OUD and NAS between 2016 and 2022. In addition, we used birth certificate-linked Medicaid data to estimate related trends among Medicaid enrollees.
RESULT: From 2016 to 2022, the prevalence of maternal OUD decreased from 35.3 to 18.8 per 1000 deliveries and the prevalence of NAS decreased from 33.2 to 14.0 per 1000 newborns (linear trend p values <0.01). Decreasing trends were also found among Medicaid enrollees.
CONCLUSION: In Maine between 2016 and 2022, there was a decrease in maternal OUD and NAS diagnoses recorded in administrative datasets. These findings should be interpreted with caution due to changes in how OUD and NAS diagnoses are recorded and COVID-related changes in healthcare utilization.
PMID:38267636 | DOI:10.1038/s41372-024-01882-x
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Trends in maternal opioid use disorder and neonatal abstinence syndrome in Maine, 2016-2022
🌐 90 Days
VR Related Evidence Matrix
- Naltrexone Compared With Buprenorphine or Methadone in Pregnancy: A Systematic Review
- Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-vaccination Serologic Testing
- Neonatal autonomic regulation as a predictor of autism symptoms in very preterm infants
- Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder
- Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review
- Effect of parental adverse childhood experiences on intergenerational DNA methylation signatures from peripheral blood mononuclear cells and buccal mucosa
- Timing of treatment for opioid use disorder among birthing people
- Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder
- Application of an opioid use disorder cascade of care in a large public health system
- Processing abnormalities in monetary outcome evaluations among male individuals with opioid use disorder: evidence from feedback-related negativity
- Prenatal cannabis use disorder and gastroschisis in California, 2007-19
- Opioid-induced hypogonadism in opioid use disorder, its role in negative reinforcement, and implications for treatment and retention
- Temporal changes in pre-existing health conditions five years prior to pregnancy in British Columbia, Canada, 2000-2019
- Diagnosis of Perinatal Mental Health Conditions Following Medicaid Expansion to Include Low-Income Immigrants
- First Trimester Use of Buprenorphine or Methadone and the Risk of Congenital Malformations
- Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients
- Case Series of Individuals Treated with Naltrexone during Pregnancy for Opioid and/or Alcohol Use Disorder
- Analysis of nonfatal suicide attempts and demographic characteristics of US military veterans with opioid use disorder: A descriptive VA medical center study
- Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus
- Emergency Department Access to Buprenorphine for Opioid Use Disorder
- The association of pain impact and sleep disruption with opioid withdrawal during opioid-use disorder treatment
- Maternal pre-pregnancy and prenatal penicillin, neonatal inflammation and growth factors are associated to ADHD in the offspring
- Leveraging neuroscience education to address stigma related to opioid use disorder in the community: a pilot study
- Leveraging neuroscience education to address stigma related to opioid use disorder in the community: a pilot study
- 'Joining the Dots: Linking Prenatal Drug Exposure to Childhood and Adolescence' - research protocol of a population cohort study
- Binge drinking in early adolescence : Results of the "Präventionsradar" from 2016 to 2023
- Characterizing Acute and Postsurgical Pain Management in Patients Receiving Buprenorphine or Buprenorphine/naloxone
- Buprenorphine: two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable form
- Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals
- Global Trends in the Incidence of Anxiety Disorders From 1990 to 2019: Joinpoint and Age-Period-Cohort Analysis Study
- The prevalence and odds of bipolar disorder in women with polycystic ovary syndrome (PCO) disease: a systematic review and meta-analysis
- Maternal asthma and asthma exacerbation during pregnancy and attention-deficit/hyperactivity disorder in offspring: a population-based cohort study
- Maternal prenatal social disadvantage and neonatal functional connectivity: Associations with psychopathology symptoms at age 12 months
- Patients' and Clinicians' Experiences with In-person, Video, and Phone Modalities for Opioid Use Disorder Treatment: A Qualitative Study
- Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in Germany
- Study of liver cirrhosis over twenty consecutive years in adults in Southern China
- Cognitive behavioral therapy for anxiety and opioid use disorder: Development and pilot testing
- Determinants of non-alcoholic fatty liver disease in young people: Maternal, neonatal, and adolescent factors
- The lived experiences and treatment needs of women with opioid use disorder and posttraumatic stress symptoms: A mixed methods study of women and providers
- Maternal and paternal licit and illicit drug use, smoking and drinking and autism spectrum disorder
- High Interest in Injectable Opioid Agonist Treatment With Hydromorphone Among Urban Syringe Service Program Participants
- Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators
- Cannabis Use Among Students in Grades 8, 10, and 12, by Sex - King County, Washington, 2008-2021
- Estimate the prevalence of daily caffeine consumption, caffeine use disorder, caffeine withdrawal and perceived harm in Iran: a cross-sectional study
- Investigating maternal and neonatal health outcomes associated with continuing or ceasing dexamphetamine treatment for women with attention-deficit hyperactivity disorder during pregnancy: a retrospective cohort study
- The impact of the affordable care act on perinatal mood and anxiety disorder diagnosis and treatment rates among Michigan Medicaid enrollees 2012-2018
- Dual and poly-nicotine and tobacco use among adolescents in the United States from 2011 to 2022
- Stepped Care for Patients to Optimize Whole Recovery (SC-POWR): An Effectiveness Trial Evaluating a Stepped Care Model for Individuals With Opioid Use Disorder and Chronic Pain
- Occurrence of postpartum manic or mixed episodes in women with bipolar I disorder: A systematic review and meta-analysis
- Do maternal anxiety and depressive symptoms predict anxiety in children with and without ADHD at 8 years?
- Stimulant Patterns, Alone or with Other Psychotropic Classes, in Medicaid-Insured Youth Continuously Enrolled for 3-8 Years
- Cost of care for Alzheimer's disease and related dementias in the United States: 2016 to 2060
- Maternal Childhood Adversity and Infant Epigenetic Aging: Moderation by Restless Sleep During Pregnancy
- Comparative Analysis of Instrumental Variables on the Assignment of Buprenorphine/Naloxone or Methadone for the Treatment of Opioid Use Disorder
- Genetic and non-genetic predictors of risk for opioid dependence
- Frequency of Prenatal Care Visits: A Core Outcome Set for Prenatal Care Schedules
- Clinical, socio-demographic, and parental correlates of early autism traits in a community cohort of toddlers
- Perinatal Posttraumatic Stress Disorder Diagnoses Among Commercially Insured People Increased, 2008-20
- Maternal and fetal/neonatal outcomes in pregnancy, delivery and postpartum following bariatric surgery and comparison with pregnant women with obesity: a study protocol for a prospective cohort
- Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies
- Medicare, Medicaid, and dual enrollment for adults with intellectual and developmental disabilities
- Maternal intrahepatic cholestasis of pregnancy and neurodevelopmental conditions in offspring: A population-based cohort study of 2 million Swedish children
- Prevalence and trend of central nervous system-active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study
- Withdrawal catastrophizing scale: initial psychometric properties and implications for the study of opioid use disorder and hyperkatifeia
Evidence Blueprint
Trends in maternal opioid use disorder and neonatal abstinence syndrome in Maine, 2016-2022
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
Save Evidence Blueprint
Save as PDF
Trends in maternal opioid use disorder and neonatal abstinence syndrome in Maine, 2016-2022
🌐 365 Days
VR Related Evidence Matrix
- The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention
- Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
- Trends in Neonatal Opioid Withdrawal Syndrome and Opioid Exposure Diagnoses Among Infants With Private Health Insurance, 2016-2021: Introduction of the P04.14 ICD-10-CM Code
- Urine drug testing among Medicaid enrollees initiating buprenorphine treatment for opioid use disorder within 9 MODRN states
- National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018
- Naltrexone Compared With Buprenorphine or Methadone in Pregnancy: A Systematic Review
- Trends, Characteristics, and Maternal Morbidity Associated With Unhoused Status in Pregnancy
- Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA
- Assessing the Impact of Indiana Public Law 194 on Curbing the Concurrent Opioid Prescribing for Indiana Medicaid Enrollees
- Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic
- Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-vaccination Serologic Testing
- Parent and grandparent neonatal intensive care unit visitation for preterm infants
- Differing time trends for alcohol misuse and alcohol use disorder among Veteran men: A comparison of population surveillance and clinical data
- The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose
- Neonatal autonomic regulation as a predictor of autism symptoms in very preterm infants
- Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder
- Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review
- Mental Health Within 24 Months After Delivery Among Women with Common Pregnancy Conditions
- Effect of parental adverse childhood experiences on intergenerational DNA methylation signatures from peripheral blood mononuclear cells and buccal mucosa
- Profiling neuronal methylome and hydroxymethylome of opioid use disorder in the human orbitofrontal cortex
- Neighborhood Income Mobility and Risk of Neonatal and Maternal Morbidity
- Timing of treatment for opioid use disorder among birthing people
- Exploring mental health comorbidities and opioid agonist treatment coverage among people in prison: A national cohort study 2010-2019
- Disparities in Perinatal and Emergency Care Receipt Among Women With Perinatal Opioid Use Disorder in Medicaid, 2007 to 2012
- Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder
- Effects of Abstinence From Opioid on Neuropsychological Performance in Men With Opioid Use Disorder: A Longitudinal Study
- High-deductible Health Plans and Nonfatal Opioid Overdose
- Did the 2021 federal change in the practice guidelines for the administration of buprenorphine for treating opioid use disorder increase buprenorphine prescription dispensing in Medicaid population?
- Association of OPRK1 rs963549 and rs997917 polymorphisms with opioid use disorder and the related phenotypes
- Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: Challenges and opportunities
- Neuroimmune mechanisms of opioid use disorder and recovery: Translatability to human studies, and future research directions
- Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019
- Psychotherapies in opioid use disorder: toward a step-care model
- Opioid use disorder treatment and the role of New Jersey Medicaid policy changes: perspectives of office-based buprenorphine providers
- Validating opioid use disorder diagnoses in administrative data: a commentary on existing evidence and future directions
- Common mental disorders and perinatal outcomes in Victoria, Australia: A population-based retrospective cohort study
- An Appraisal of Using Opioids in Patients with Opioid Use Disorder
- State-to-State Variation in Opioid Dispensing Changes Following the Release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain
- Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder
- Initiation of Extended-release Depot Buprenorphine in a Patient Subject to a Community Treatment Order for Both Antipsychotic and Opioid Agonist Treatments
- Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder
- Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder - a narrative review
- Application of an opioid use disorder cascade of care in a large public health system
- Processing abnormalities in monetary outcome evaluations among male individuals with opioid use disorder: evidence from feedback-related negativity
- Prenatal cannabis use disorder and gastroschisis in California, 2007-19
- Opioid-induced hypogonadism in opioid use disorder, its role in negative reinforcement, and implications for treatment and retention
- Temporal changes in pre-existing health conditions five years prior to pregnancy in British Columbia, Canada, 2000-2019
- Diagnosis of Perinatal Mental Health Conditions Following Medicaid Expansion to Include Low-Income Immigrants
- Trends in intentional and unintentional poisonings among older adults - A national register-based study in Sweden
- Non-overdose acute care hospitalizations for opioid use disorder among commercially-insured adults: a retrospective cohort study
- Levels and trends in mortality and causes of death among women of reproductive age in Bangladesh: Findings from three national surveys
- First Trimester Use of Buprenorphine or Methadone and the Risk of Congenital Malformations
- Change in opioid and buprenorphine prescribers and prescriptions by specialty, 2016-2021
- Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid Programs
- Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients
- Identification of opioid use disorder using electronic health records: Beyond diagnostic codes
- Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder
- Extended-release Buprenorphine Administered at Discharge in Hospitalized Persons With Opioid Use Disorder: A Case Series
- Case Series of Individuals Treated with Naltrexone during Pregnancy for Opioid and/or Alcohol Use Disorder
- Analysis of nonfatal suicide attempts and demographic characteristics of US military veterans with opioid use disorder: A descriptive VA medical center study
- Transcriptional signatures of heroin intake and relapse throughout the brain reward circuitry in male mice
- Pregnancy characteristics and outcomes among birthing individuals with a diagnosis of fetal alcohol syndrome
- Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus
- Framing Chronic Pain in U.S. News Coverage of the Opioid Epidemic (2012-2022)